ACADIA Pharmaceuticals Inc. (ACAD) Fundamentals

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
SHARE INFORMATION
Market Cap$ 2,811,216,123
Shares Outstanding161,843,185
Float119,652,372
Percent Float73.93%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 484,145,000
Latest Fiscal EPS$ -1.05
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions577
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months11,983,381
Institutional Holdings Percent134.0%
Institutional Sold Previous 3 Months27,590,781
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months207,357
Insider Holdings Percent0.5
Insider Sold Previous 3 Months39,607
Insider Shares Owned731,076
TRADING INFO
52 Week High$ 28.06
52 Week Low$ 12.24
52 Week High Change$ 3.89
21 Day Moving Average$ 15.5762
21 Day Extended Moving Average$ 16.0234
50 Day Moving Average$ 15.6776
50 Day Extended Moving Average$ 16.1882
200 Day Moving Average$ 20.418
200 Day Extended Moving Average$ 19.6995
10 Day Average Volume1,983,551
20 Day Average Volume1,728,833
30 Day Average Volume1,794,607
50 Day Average Volume2,922,764
Alpha-0.005983
Beta0.7074
Standard Deviation0.158556
R20.049794
7 Day Price Change$ 1.63
7 Day Percent Change10.36%
21 Day Price Change$ 2.79
21 Day Percent Change19.14%
30 Day Price Change$ 2.36
30 Day Percent Change15.72%
Month to Date Price Change$ 2.68
Month to Date Percent Change18.24%
Quarter to Date Price Change$ 3.28
Quarter to Date Percent Change23.28%
180 Day Price Change$ -8.49
180 Day Percent Change-32.83%
200 Day Price Change$ -4.74
200 Day Percent Change-21.44%
Year to Date Price Change$ -5.97
Year to Date Percent Change-25.58%

ACADIA Pharmaceuticals Inc. (ACAD) Key Ratios

PROFITABILITY
EBIT Margin-40.3%
EBITDA Margin-39.8%
Pre-Tax Profit Margin-101.1%
Profit Margin Count-40.03%
Gross Margin97.1%
Profit Margin TOT-40.03%
INCOME STATEMENTS
Revenue$ 512,401,000
Revenue Per Share$ 3.166
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book6.40
Total Debt To Equity0.20
Int Coverage0.00
Current Ratio4.50
Leverage Ratio1.30
Quick Ratio4.30
Long Term Debt To Capital0.11
VALUATION MEASURES
PE Ratio-13.40
Enterprise Value$ 2,388,410,736
Price to Sales5.4864
Price to Free Cash-21.30
PE High Last 5 Years-14.00
Price To Book6.40
Price To Cash Flow0.00
PE Low Last 5 Years-18.80
Price to Tangible Book6.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover8.70
Invoice Turnover1.90
Assets Turnover0.80
Return Assets-32.66
Return on Equity-43.82
Return on Capital-36.31

ACADIA Pharmaceuticals Inc. (ACAD) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOStephen R. Davis
Emplyoees500
Last AuditUQ
CIK0001070494
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address12830 El Camino Real
Suite 400
San Diego, CA 92130
Websitehttps://www.acadia-pharm.com
Facsimile+1 858 212-0513
Telephone+1 858 558-2871
Emailir@acadia-pharm.com


Your Recent History
NASDAQ
ACAD
Acadia Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.